Radiotherapy-Induced Otitis Media With Effusion in Nasopharyngeal Carcinoma: A Meta-Analysis.
Nevin Yi Meng Chua, Yong Hoe Chan, Woei Shyang Loh et al.
✦ AI-curated · Sources linked
In 30 seconds
This meta-analysis pooled observational studies of otitis media with effusion (OME) after radiotherapy in patients with nasopharyngeal carcinoma. Eight studies comprising 10 cohorts included 582 patients; the overall analysis of 962 patients reported a risk difference of 0.08 (95% CI: 0.01-0.15, p = 0.0078). Technique-specific estimates were 0.18 for conventional two-dimensional radiotherapy, 0.18 for three-dimensional conformal radiotherapy, and 0.19 for intensity-modulated radiotherapy (IMRT). Chemotherapy exposure and cancer stage were not significantly associated with OME.
Key findings
- Across 962 patients, the overall risk difference for OME after radiotherapy was 0.08 (95% CI: 0.01-0.15, p = 0.0078).
- Technique-specific OME risk estimates were 0.18 for 2D-RT, 0.18 for 3D-CRT, and 0.19 for IMRT.
- Chemotherapy exposure and nasopharyngeal carcinoma stage showed no significant association with OME.
Why it matters
OME is a frequent otologic toxicity after radiotherapy for nasopharyngeal carcinoma. The pooled estimates quantify this risk and describe variation by radiotherapy technique, providing context for discussing potential ear-related effects and considering follow-up. The findings also indicate that chemotherapy exposure and cancer stage were not significantly associated with OME in the included evidence.
What to keep in mind
The synthesis included observational studies, so the findings do not establish causation. Technique-specific estimates have wide confidence intervals, including intervals that cross zero.